DMAA insider transaction filings
Drugs Made In America Acquisition Corp. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-02-18. Screen DMAA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-18 | 4 | Drugs Made In America Acquisition LLC — 10% owner | Purchase (P): 30,000 · Purchase (P): 30,000 (derivative) | EDGAR |
| 2025-02-18 | 4 | Stockwell Lynn — CEO and Exe. Chair of Board, Director, 10% owner | Purchase (P): 30,000 · Purchase (P): 30,000 (derivative) | EDGAR |
| 2025-02-04 | 4 | Drugs Made In America Acquisition LLC — 10% owner | Purchase (P): 400,000 · Other (J): 400,000 · Sale (S): 5,698,363 · Purchase (P): 400,000 (derivative) | EDGAR |
| 2025-02-04 | 4 | Stockwell Lynn — CEO and Executive COB, Director, 10% owner | Purchase (P): 400,000 · Other (J): 400,000 · Sale (S): 5,698,363 · Purchase (P): 400,000 (derivative) | EDGAR |
| 2025-02-03 | 4 | Shulgan Myron W. — Director | Other (J): 100,000 | EDGAR |
| 2025-02-03 | 4 | Prasad Sridhar G. — Director | Other (J): 100,000 | EDGAR |
| 2025-02-03 | 4 | Do Catherine — Director | Other (J): 100,000 | EDGAR |
| 2025-02-03 | 4 | Worman Glenn C. — CFO | Other (J): 100,000 | EDGAR |
Recent 8-K events — Drugs Made In America Acquisition Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-02-25 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DMAA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →